Enhanced Drug Access to Eye Tissues

Award Information
Agency:
Department of Health and Human Services
Amount:
$232,945.00
Program:
SBIR
Contract:
1R43EY015606-01
Solitcitation Year:
2004
Solicitation Number:
PHS2004-2
Branch:
N/A
Award Year:
2004
Phase:
Phase I
Agency Tracking Number:
EY015606
Solicitation Topic Code:
N/A
Small Business Information
NACELLE THERAPEUTICS, INC.
NACELLE THERAPEUTICS, INC., 1500 HAYES DR, MANHATTAN, KS, 66502
Hubzone Owned:
N
Woman Owned:
N
Socially and Economically Disadvantaged:
N
Duns:
N/A
Principal Investigator
 JOHN Tomich
 (785) 532-3900
 JTOMICH@KSU.EDU
Business Contact
 GARY RABOLD
Phone: (785) 532-3906
Email: GRABOLD@KSU.EDU
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant) The innovative use of a synthetic peptide to modulate epithelial cell-cell interactions is proposed for the augmentation of drug- or gene-based therapeutic interventions. Cell monolayers are a major obstacle to deli

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government